肿瘤研究与临床
腫瘤研究與臨床
종류연구여림상
Cancer Research and Clinic
2015年
8期
532-534
,共3页
冯希梅%郭淑丽%田永芳%陈程%王洪丽
馮希梅%郭淑麗%田永芳%陳程%王洪麗
풍희매%곽숙려%전영방%진정%왕홍려
前列腺肿瘤%锶%放射性核素治疗%骨转移
前列腺腫瘤%鍶%放射性覈素治療%骨轉移
전렬선종류%송%방사성핵소치료%골전이
Prostatic neoplasms%Strontium%Radionuclide therapy%Bone metastasis
目的 对比分析维吾尔族和汉族前列腺癌骨转移患者氯化锶(89SrCl2)治疗的效果.方法 75例维吾尔族和82例汉族前列腺癌骨转移患者静脉注射89SrCl2后,观察其镇痛效果,单光子发射计算机断层成像术(SPECT)监测骨转移灶,电化学发光法测定前列腺特异性抗原(PSA)和白细胞介素-6(IL-6)的变化.结果 89SrCl2治疗后,维吾尔族患者镇痛有效率为82.67%(62/75),高于汉族患者的60.98%(50/82)(P< 0.05);维吾尔族患者骨转移灶治疗有效率74.67%(56/75),高于汉族患者的52.44%(43/82)(P<0.05);维吾尔族患者IL-6降低水平为(4.24±1.74) pg/ml,高于汉族患者的(2.81±2.38)pg/ml(P< 0.05).结论 89SrCl2治疗维吾尔族前列腺癌骨转移患者比治疗汉族患者疗效更好,临床应加以重视.
目的 對比分析維吾爾族和漢族前列腺癌骨轉移患者氯化鍶(89SrCl2)治療的效果.方法 75例維吾爾族和82例漢族前列腺癌骨轉移患者靜脈註射89SrCl2後,觀察其鎮痛效果,單光子髮射計算機斷層成像術(SPECT)鑑測骨轉移竈,電化學髮光法測定前列腺特異性抗原(PSA)和白細胞介素-6(IL-6)的變化.結果 89SrCl2治療後,維吾爾族患者鎮痛有效率為82.67%(62/75),高于漢族患者的60.98%(50/82)(P< 0.05);維吾爾族患者骨轉移竈治療有效率74.67%(56/75),高于漢族患者的52.44%(43/82)(P<0.05);維吾爾族患者IL-6降低水平為(4.24±1.74) pg/ml,高于漢族患者的(2.81±2.38)pg/ml(P< 0.05).結論 89SrCl2治療維吾爾族前列腺癌骨轉移患者比治療漢族患者療效更好,臨床應加以重視.
목적 대비분석유오이족화한족전렬선암골전이환자록화송(89SrCl2)치료적효과.방법 75례유오이족화82례한족전렬선암골전이환자정맥주사89SrCl2후,관찰기진통효과,단광자발사계산궤단층성상술(SPECT)감측골전이조,전화학발광법측정전렬선특이성항원(PSA)화백세포개소-6(IL-6)적변화.결과 89SrCl2치료후,유오이족환자진통유효솔위82.67%(62/75),고우한족환자적60.98%(50/82)(P< 0.05);유오이족환자골전이조치료유효솔74.67%(56/75),고우한족환자적52.44%(43/82)(P<0.05);유오이족환자IL-6강저수평위(4.24±1.74) pg/ml,고우한족환자적(2.81±2.38)pg/ml(P< 0.05).결론 89SrCl2치료유오이족전렬선암골전이환자비치료한족환자료효경호,림상응가이중시.
Objective To analyze contrastly the effect of 89SrCl2 for bone metastasis in Uygur and Han patients with prostate cancer.Methods The curative effects in 75 Uygur and 82 Han patients with prostate cancer bone metastasis were investigated after intravenous injection with 89SrCl2,including palliation of pain.SPECT was used to detect the change of metastasis,level of prostate-specific antigen (PSA) and interleukin-6 (IL-6) were detected by electrochemiluminescence immunoassay.Results After treated with 89SrCl2,the palliation rate,the bone metastases and the level of IL-6 were higher in Uygur patients [82.67 % (62/75),75 % (56/75),(4.24±1.74) pg/ml] than those in Han patients [60.98 % (50/82),52.44 % (43/82),(2.81±2.38) pg/ml],and there were statistically significant (P < 0.05).Conclusion 89SrCl2 is more effective for the Uygur patients with prostate cancer bone metastasis than the Han patients,clinical workers should pay more attention to this.